v3.25.1
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Revenue:    
Net sales $ 39,081,657
Cost of sales (1,596,715) (818,539)
Gross profit (loss) 37,484,942 (818,539)
Operating Expenses    
Research and development (3,192,440) (837,445)
Selling and marketing (4,473,840) (6,337,219)
General and administrative (9,693,382) (8,711,033)
Total operating expenses (17,359,662) (15,885,697)
Income (Loss) From Operations 20,125,280 (16,704,236)
Other Income (Expense)    
Interest income 566,797 857,186
Foreign exchange transaction (loss) gain (38,172) (4,008)
Interest expense (10,007) (9,835)
Total other income 518,618 843,343
Net Income (Loss) Before Income Taxes 20,643,898 (15,860,893)
Tax (provision) benefit 1,394,770
Net Income (Loss) 20,643,898 (14,466,123)
Other Comprehensive (Loss) Income    
Unrealized loss from investment (4,511) (10,903)
Foreign currency translation (loss) gain (1,579) 256
Total other comprehensive loss (6,090) (10,647)
Other Comprehensive Income (Loss) $ 20,637,808 $ (14,476,770)
Net Income (Loss) Per Common Share - Basic (in Dollars per share) $ 0.32 $ (0.25)
Net Income (Loss) Per Common Share - Diluted (in Dollars per share) $ 0.3 $ (0.25)
Weighted Average Common Shares Outstanding - Basic (in Shares) 65,244,341 57,503,154
Weighted Average Common Shares Outstanding - Diluted (in Shares) 68,975,418 57,503,154